Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia

Archives of Surgery

Volumn 131, Issue 1, 1996, Pages 51-56

  Ertel, Wolfgang ^a,b   Keel, Marius ^a   Steckholzer, Ursula ^a   Ungethüm, Udo ^a   Trentz, Otmar ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CELL FUNCTION; CONTROLLED STUDY; ENDOTOXEMIA; GENE REPRESSION; GRAFT REJECTION; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL;

EID: 0030025282     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430130053009     Document Type: Article

References (31)

1. Tracey KJ, Lowry SF The role of cytokine mediators in septic shock. Adv Surg. 1990;23:21-56.
2. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg. 1993; 128.1235-1241.
3. Fisher CJ Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA. 1994;271:1836-1843.
4. Fisher CJ, Opal SM, Dhainaut JF, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis Crit Care Med. 1993;21:318-327.
5. Abraham E, Raffin TA Sepsis therapy trials - continued disappointment or rea-son for hope? JAMA 1994;271:1876-1878.
6. Moore KW, O'Garra A, deWaal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993;11:165-190.
7. Fiorentino DF, Zlotnik A, Mosmann TR, Howard MH, O'Garra A, IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815-3822.
8. Ralph P, Nakoinz I, Sampson-Johannes A, et al. IL-10, T lymphocyte inhibitor of human Wood cell production of IL-1 and tumor necrosis factor. J Immunol. 1992:148 808-814.
9. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interteukin 10. J Exp Med. 1991;174 1549-1555
10. Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J. Biological properties of interleukin-10. J Clin Immunol 1992;12:239-247.
11. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 1993;177:547-550
12. Howard M, Muchamuet T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-1208.
13. deWaal Malefyt R, Haanen J, Spits H, et al. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression J Exp Med. 1991;174:915-924
14. Taga K, Tosato G. IL-10 inhibits T cell proliferation and IL-2 production. J Immunol. 1992;148:1143-1148.
15. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function J Immunol. 1992;148:3133-3139
16. Fiorentino DF, Zlotnik A, Vieira A, et al IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146:3444-3451.
17. Hsu DH, Moore KW, Sprts H Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int Immunol. 1992;4:563-569.
18. Ertel W, Morrison MH, Ayala A, Dean RE, Chaudry IH Interferon-γ attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery. 1992;111:177-187.
19. Ertel W, Morrison MH, Ayala A, Chaudry IH Chloroquine attenuates hemorrhagic shock-induced suppression of Kupffer cell antigen presentation and major histocompatibility complex class II antigen expression through blockade of tumor necrosis factor and prostaglandin release Blood. 1991;78:1781-1788.
20. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH. Anti-TNF antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression Immunology 1991;74:290-297
21. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg. 1993;128:89-95.
22. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased sptenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production. J Surg Res. 1994;56 579-585.
23. Ayala A, Lehman DL, Herdon CD, Chaudry IH. Mechanism of enhanced susceptibility to sepsis following hemorrhage. Arch Surg. 1994;129:1172-1178.
24. Silva AT, Bayston KF Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock. J Infect Dis 1990,162:421-427
25. Zanetti G, Heumann D, Gerain J, et al Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. J Immunol 1992,148:1890-1897
26. Kohler J, Heumann D, Garotta G, et al. IFN-γ involvement in the severity of gram-negative infections in mice J Immunol 1993;151:916-921.
27. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318.1481-1486.
28. Fiorentino DF, Bond MW. Mosmann TR Two types of mouse T helper cells: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081-2095.
29. Marchant A, Bruyns C, Vandenabeele P, et al. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24.1167-1171
30. Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. J Leukoc Biol. 1994,55:711-718.
31. Ertel W, Kremer JP, Kenney J, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995;85:1341-1347.